Key Highlights
- Acclarent's Balloon Sinuplasty technology has been used in over 535,000 procedures, demonstrating its effectiveness and widespread adoption.
- The company focuses on minimally invasive procedures that preserve nasal anatomy, addressing conditions like rhinosinusitis and Eustachian Tube Dysfunction.
- Acclarent's commitment to innovation and patient care positions it as a leader in the ENT medical device market.
- The company's technologies are designed to enhance patient outcomes and reduce recovery times.
- Acclarent's strategic focus on minimally invasive solutions sets it apart in the competitive medical device industry.
About Acclarent
Acclarent, Inc., part of Integra LifeSciences, is a medical device company based in Irvine, California that specializes in minimally invasive technologies for Ear, Nose, and Throat (ENT) surgeons. Established in June 2004, Acclarent focuses on preserving nasal anatomy while addressing conditions like rhinosinusitis and persistent Eustachian Tube Dysfunction. Their flagship product, Balloon Sinuplasty, launched in 2005, has been utilized in over 535,000 procedures by otolaryngologists.
The company's mission is to support ENT surgeons with innovative solutions that enhance patient outcomes. Acclarent's technologies are designed to be minimally invasive, ensuring that the natural nasal anatomy is preserved during treatment. This approach not only improves patient recovery but also reduces the risk of complications.
With a team of 219 employees, Acclarent continues to lead in the development of advanced ENT technologies. Their commitment to innovation and patient care makes them a key player in the medical device industry.
Company Facts
| Ownership Private Company |
| Stock IART (NASDAQ) |
| Funding $61M |
| Parent Company Integra LifeSciences |
Why Contact Acclarent?
B2B professionals should contact Acclarent for partnerships in minimally invasive ENT technologies and to explore vendor opportunities in the medical device market. Their innovative solutions and commitment to patient care make them a valuable partner for companies looking to advance in the ENT field.
Who Should Contact Acclarent for Business?
Sales teams selling medical devices, ENT surgeons, and medical technology vendors should reach out to Acclarent. Recruiters seeking roles in medical device innovation and partners offering advanced ENT technologies should also consider this company.
Categories
- Medical Devices
- ENT Technologies
- Minimally Invasive
- Balloon Sinuplasty
- Rhinosinusitis
- Eustachian Tube Dysfunction
- ENT Surgeons
- Innovation
- Patient Care
- Medical Technology
Similar Companies
Companies that compete with or operate in similar markets to Acclarent:
- Earlens Corp
More Medical Devices Companies
Frequently Asked Questions
- Who is the CEO of Acclarent?
- While Bill Facteau previously served as President and CEO, the current executive leadership under its new parent company, Integra LifeSciences, is not explicitly named in the provided snippets.
- What does Acclarent do?
- Acclarent is a medical device company that develops and commercializes minimally invasive technologies for Ear, Nose, and Throat (ENT) surgical interventions, including balloon sinuplasty and Eustachian tube balloon dilation.
- How many employees does Acclarent have?
- Acclarent has approximately 240 employees.
- Where is Acclarent headquartered?
- The company is headquartered in Irvine, Orange County, California.
- What industry is Acclarent in?
- Acclarent operates in Medical Devices, ENT Technologies, Minimally Invasive Procedures.
- When was Acclarent founded?
- Acclarent was founded in 2004.
- What is the email format at Acclarent?
- Acclarent uses the email format flast@acclarent.com.
- How do I contact the founder of Acclarent?
- The founder of Acclarent can be contacted at jchang@acclarent.com.
- Is Acclarent still active?
- Yes, Acclarent was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Acclarent?
- Research Acclarent's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Acclarent?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Acclarent